Alzheimer’s Disease and Specialized Pro-Resolving Lipid Mediators: Do MaR1, RvD1, and NPD1 Show Promise for Prevention and Treatment?

Alzheimer’s disease (AD) is a common neurodegenerative disease and a major contributor to progressive cognitive impairment in an aging society. As the pathophysiology of AD involves chronic neuroinflammation, the resolution of inflammation and the group of lipid mediators that actively regulate it—i...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyazawa, Keishi, Fukunaga, Hisanori, Tatewaki, Yasuko, Takano, Yumi, Yamamoto, Shuzo, Mutoh, Tatsushi, Taki, Yasuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460933/
https://www.ncbi.nlm.nih.gov/pubmed/32806612
http://dx.doi.org/10.3390/ijms21165783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460933/
https://www.ncbi.nlm.nih.gov/pubmed/32806612
http://dx.doi.org/10.3390/ijms21165783

Ejemplares similares